Question 1

Has Joseph Ray received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $642,184 in general payments to Joseph Ray across 693 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Joseph Ray did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Joseph Ray come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Sanofi	379	$403,306
Biomarin Pharmaceutical Inc.	169	$115,753
Mirum Pharmaceuticals, Inc.	77	$82,559
PTC Therapeutics, Inc.	21	$16,469
Sarepta Therapeutics, Inc.	14	$6,312
Chiesi USA, Inc.	7	$6,177
Travere Therapeutics, Inc.	6	$5,346
Amicus Therapeutics, Inc.	2	$3,036
ITF Therapeutics LLC	2	$2,650
Novartis	2	$209
Ultragenyx Pharmaceutical Inc.	5	$154
AstraZeneca	2	$67
Sanofi-aventis U.S. LLC	2	$33
Cycle Pharmaceuticals Inc	1	$26
Shire North American Group Inc	1	$24
Sanofi US Services Inc.	1	$22
Kyowa Kirin, Inc.	1	$21
Pharming Healthcare, Inc.	1	$19

Joseph Ray

Payments from drug & device makers

Who reported the general payments

How this compares

Other clinical genetics (m.d.) in Galveston